One Capital Management, LLC Halozyme Therapeutics, Inc. Transaction History

One Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$40.06 - $59.44 $85,127 - $126,310	-2,125 Reduced 17.42%	10,075 $573,000
Q4 2021 Jan 31, 2022	SELL	$31.82 - $40.75 $922 - $1,181	-29 Reduced 0.24%	12,200 $490,000
Q3 2021 Nov 12, 2021	SELL	$38.47 - $46.42 $461,640 - $557,040	-12,000 Reduced 49.53%	12,229 $497,000
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $941,054 - $1.24 Million	24,229 New	24,229 $1.1 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of One Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on One Capital Management, LLC with notifications on news.